The novel approach of the medication represents a exciting advance in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide702951.onzeblog.com/42266272/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment